Reversal of Neuromuscular Blockade With Sugammadex or Usual Care in Hip Fracture Surgery or Joint (Hip/Knee) Replacement (P07038)

Clinical trial NCT01422304 · COMPLETED

Trial details

NCT number: NCT01422304
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Neuromuscular Blockade Arthroplasty, Replacement, Hip Arthroplasty, Replacement, Knee Blood Coagulation Antithrombotic Agents

Start date: 2011-10-12
Primary completion: 2012-09-26
Enrollment: 1198

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.